Product Overview
Closer to Autograft Than Ever Before.
OSTEOAMP has been shown to retain up to 23 natural growth factors that support bone formation.
OSTEOAMP is backed by science to meet the surgeon's need for a proven allograft that can achieve solid fusion outcomes.
The OSTEOAMP Difference
• Our proprietary method of processing bone and bone marrow makes OSTEOAMP different from demineralized bone matrix (DBM) products that strip away bone marrow during processing, which reduces their potential for initiating osteoinduction and angiogenesis.
• Peer-reviewed publications report that OSTEOAMP is a viable alternative to Infuse®, based on fusion rates and time to fusion in lumbar spine fusion.
Economics
• OSTEOAMP has been shown to be 73.7% less expensive per level than Infuse in one published study where 321 patients were evaluated in a TLIF/LLIF approach.
Safety
• Donor bone is sourced from AATB-certified and FDA-registered tissue banks in the United States.
• All tissues are screened for the standard panel of infectious viruses.
• Manufacturing and sterilization processes have been validated to inactivate HIV-1, Bovine Herpes Virus (BHV), Bovine Viral Diarrhea Virus (BVDV), Hepatitis A Virus (HAV) and Porcine Parvovirus (PPV).
Three formats to meet the unique needs of your patient:
• Granules
OSTEOAMP granules combine osteoconductive and osteoinductive properties with mineralized cortical-cancellous allograft chips.
• Putty
All formats may be rehydrated with bone marrow aspirate, blood, or saline. For optimal handling of the putty, bone marrow aspirate or blood are recommended.
• Sponge
Combines both osteoconductive and osteoinductive properties in an easy-to-use compressible sponge. The malleable implant readily conforms to various interbody devices and/or bony defects.
(https://www.bioventusglobal.com)
